| top of page |
| Details of the target gene |
| Gene Model of Rodent Parasite |
PBANKA_1400800
|
| Gene Model P. falciparum ortholog |
PF3D7_1302200
|
| Gene product | early transcribed membrane protein 13 |
| Gene product: Alternative name | UIS3 |
| top of page |
| Details of the genetic modification |
| Name of the tag | c-myc |
| Details of tagging | C-terminal |
| Additional remarks: tagging | triple c-myc |
| Commercial source of tag-antibodies | |
| Type of plasmid/construct | (Linear) plasmid single cross-over |
| PlasmoGEM (Sanger) construct/vector used | No |
| Modified PlasmoGEM construct/vector used | No
|
| Plasmid/construct map |
|
| Plasmid/construct sequence |
|
| Restriction sites to linearize plasmid |
|
| Selectable marker used to select the mutant parasite | hdhfr |
| Promoter of the selectable marker | unknown |
| Selection (positive) procedure | WR99210 |
| Selection (negative) procedure | No |
| Additional remarks genetic modification | The mutant expresses a C-termnal triple Myc tagged version of UIS3. In this study an existing mutant lacking the uis3 gene has been complemented with a triple Myc tagged version of uis3.
The gene has been introduced by a single cross-over construct containing the hdhfr gene (selection with the drug WR99210) |
| Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| Sequence Primer 1 | |
| Additional information primer 1 | |
| Sequence Primer 2 | |
| Additional information primer 2 | |
| Sequence Primer 3 | |
| Additional information primer 3 | |
| Sequence Primer 4 | |
| Additional information primer 4 | |
| Sequence Primer 5 | |
| Additional information primer 5 | |
| Sequence Primer 6 | |
| Additional information primer 6 | |
|
|
| top of page |